Proposed reforms to product liability law extending to digital products, including AI, together with a Law Commission consultation on a consumer class action regime, could increase the prospect of patient-led opt-out claims being pursued under consumer law rather than negligence. The Law Commission is consulting on proposed changes to product liability law, including whether digital technologies such as AI should qualify as products. The outcome of the review could reshape the balance between product liability and clinical negligence claims, including where clinicians recommend health-monitoring apps. Separately, the Commission is considering whether opt-out consumer class actions, currently largely confined to competition law, should be extended. Such a development could increase aggregation risk, enabling large volumes of similar claims to be pursued through a single consumer law mechanism.